DRUG · Unmapped registry intervention
FT836
Find medicine records ·
Find other trials using this name
Clinical trial
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
NCT07216105
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Cetuximab
Normalized identity: cetuximabView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Trastuzumab
Normalized identity: trastuzumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Colorectal Cancerverified · MONDO: colorectal cancer
Breast Cancerverified · MONDO: breast cancer
Ovarian Cancerverified · MONDO: ovarian cancer
Interventions
FT836DRUG
CetuximabDRUG · verified · RxNorm: cetuximab
TrastuzumabDRUG · verified · RxNorm: trastuzumab
Sponsors & collaborators
Fate Therapeuticslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07216105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.